PFIZER

The companies whose shares are moving in pre-market trade on Tuesday are: Metropcs Communication, Firstenergy Corp, Avon Products, Tenet Healthcare, Molson Coors Brewing, Caterpillar, Sears Holdings, Chesapeake Energy, Cognizant Technology Solutions and Pfizer.

U.S. drugmaker Pfizer Inc reported quarterly results roughly in line with expectations and said it expects by the second half of the year to complete its review of which company businesses are appropriate to keep.

Pfizer Inc is expected to report slightly lower quarterly earnings on Tuesday, but investors will be more focused on any signs the world's biggest drugmaker will further shrink itself to weather looming competition from generic drugs for its Lipitor cholesterol fighter.

The companies whose shares are moving in pre-market trade on Monday are: International Game Technology, Advanced Micro Devices, Micron Technology, Tesoro Corp, Pfizer, Netflix, FirstEnergy, Kimberly-Clark Corp, RadioShack and First Horizon National.

The top pre-market NASDAQ Stock Market gainers are: Tasty Baking, Global Crossing, American Medical Systems Holdings, RAM Energy Resources, and VIVUS. The top pre-market NASDAQ Stock Market losers are: Sina, Medivation, Energy Conversion Devices, JetBlue Airways, and Netflix.

Pfizer Inc has agreed to sell its Capsugel unit, the world's largest maker of hard capsules, to private equity firm KKR & Co for nearly $2.38 billion.

U.S. stocks advanced in early trade on Monday as investors looked to extend a two-week winning streak in the major indexes.

Pfizer Inc. (NYSE: PFE) said it agreed to sell its Capsugel business, a maker of hard capsules, to private equity firm Kohlberg Kravis Robert & Co. for $2.375 billion in cash.

Pfizer Inc. (NYSE: PFE) said on Monday it has received a Refusal-to-File letter from the United States Food and Drug Administration (FDA) for tafamidis, the company’s oral investigational compound for patients with Transthyretin Familial Amyloid Polyneuropathy (TTR-FAP).

Regulatory pressure prompted Sanofi-Aventis and Merck & Co to abandon plans for a joint animal health powerhouse with $5 billion in sales.

Drugmaker Eli Lilly , which faces plunging sales due to competition and lapsing patents, will not merge with another peer to ride out any rough times ahead, chief executive John Lechleitr said on Saturday.

Microsoft and federal agents took down Rustock, a botnet responsible at its peak for nearly half of the world's spam.

The companies whose shares are moving in pre-market trade on Monday are: Family Dollar Stores, Lorillard, Frontier Communications, Ameren, PNC Financial Services, MetLife, Novellus Systems, Novellus Systems, Marshall & Ilsley and Pfizer.

Health regulators want more data on Protalix Biotherapeutics Inc and Pfizer Inc's experimental drug for Gaucher disease before deciding whether to approve the therapy for patients with the rare genetic disorder.

Biogen Idec stock price can appreciate to the mid $70s based on five areas of potential upside, according to RBC Capital Markets. The brokerage upgraded its rating on shares of the biotechnology company to outperform from sector perform and increased its price target to $75 from $60.

Pfizer Inc said it has settled all outstanding lawsuits involving accusations that it tested the experimental antibiotic Trovan on children in Nigeria during a 1996 meningitis outbreak without receiving adequate prior consent.

Big pharmaceutical companies could face increased competition from generic drugmakers under two proposals put forth by the Obama administration on Monday.

A new virtual entrepreneurship hub from the New York University will now enable technology innovation and startup formation within the campus community by providing a growing array of entrepreneurial resources, programs, and activities online.

The top pre-market NASDAQ stock market gainers are: Glu Mobile, Orexigen Therapeutics, Veeco Instruments, Progenics Pharmaceuticals, and InterDigital. The top pre-market NASDAQ stock market losers are: Questcor Pharmaceuticals, Yongye International, Kandi Technologies, China Agritech, and Cognizant Technology Solutions.

World stocks punched fresh 29-month highs on Wednesday, lifted by strong data pointing to sustained global economic recovery, continuing positive corporate earnings and easing concerns about Egypt.

Swiss drugmaker Roche struck a cautious note on 2011, as the sector grapples with U.S. healthcare reforms and a push in Europe for lower drug prices, after growth of its top-seller Avastin slowed sharply in 2010.